Psychopharmacology of Pediatric Anxiety Disorders: A Narrative Review

被引:6
|
作者
Amray, Afshan N. [1 ,2 ]
Munir, Khurram [3 ]
Jahan, Nusrat [4 ]
Motiwala, Fatima B. [5 ]
Naveed, Sadiq [6 ]
机构
[1] Dow Univ Hlth Sci, Dow Med Coll, Med, Karachi, Pakistan
[2] Dow Univ Hlth Sci, Civil Hosp Karachi, Karachi, Pakistan
[3] Sheikh Zayed, Physiol, Rahim Yar Khan, Pakistan
[4] Rush Univ, Internal Med, Med Ctr, Chicago, IL 60612 USA
[5] Texas Tech Univ, Hlth Sci Ctr, Psychiat, Midland, TX USA
[6] Univ Kansas, Med Ctr, Psychiat, Kansas City, MO USA
关键词
anxiety; youth; psychopharmacology; PREPUBERTAL CHILDREN; CONTROLLED-TRIAL; SOCIAL PHOBIA; ADOLESCENTS; CHILDHOOD; PLACEBO; SERTRALINE; VENLAFAXINE; PAROXETINE; CLONAZEPAM;
D O I
10.7759/cureus.5487
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anxiety disorders are common among children and adolescents; almost one-third of this population has an anxiety disorder. The most common anxiety disorders in this population are specific phobia (19.3%), social anxiety disorder/social phobia (9.1 %), and separation anxiety disorder (7.6 %). Pediatric anxiety disorders are often associated with poor psychosocial functioning, academic underachievement, learning difficulties, substance abuse, relationship problems, and suicide behaviors. Psychotherapy, particularly cognitive behavioral therapy as a stand-alone treatment or in combination with medication, is found to be efficacious in the treatment of various anxiety disorders. The early recognition and treatment of anxiety disorders result in better long-term outcomes in children and adolescents. This article summarizes the evidence-based pharmacologic treatments for anxiety disorders in youth, including social anxiety disorder generalized anxiety disorder, separation anxiety disorder, and panic disorder.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Psychopharmacology interventions for pediatric anxiety disorders: A research update
    Waslick, B
    [J]. CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2006, 15 (01) : 51 - +
  • [2] PSYCHOPHARMACOLOGY OF THE ANXIETY DISORDERS
    BALLENGER, JC
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 1984, 7 (04) : 757 - 771
  • [3] Pediatric psychopharmacology: mood, anxiety and disruptive behavior/pervasive developmental disorders
    Christopher J. McDougle
    John H. Krystal
    [J]. Psychopharmacology, 2007, 191 : 1 - 3
  • [4] Pediatric psychopharmacology: mood, anxiety and disruptive behavior/pervasive developmental disorders
    McDougle, Christopher J.
    Krystal, John H.
    [J]. PSYCHOPHARMACOLOGY, 2007, 191 (01) : 1 - 3
  • [5] Treatment of pediatric anxiety disorders: An open-label extension of the Research Units on Pediatric Psychopharmacology Anxiety Study
    Walkup, J
    Labellarte, M
    Riddle, MA
    Pine, DS
    Greenhill, L
    Fairbanks, J
    Klein, R
    Davies, M
    Sweeney, M
    Abikoff, H
    Hack, S
    Klee, B
    Bergman, RL
    Lynn, D
    McCracken, J
    March, J
    Gammon, P
    Kline, N
    Robinson, J
    O'Hara, T
    Baker, S
    Vitiello, B
    Ritz, L
    Roper, M
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2002, 12 (03) : 175 - 188
  • [6] Treatment Implications of Sleep-Related Problems in Pediatric Anxiety Disorders: A Narrative Review of the Literature
    Wan Jie Tan
    Melissa S. L. Ng
    Shi Hui Poon
    Tih Shih Lee
    [J]. Child Psychiatry & Human Development, 2023, 54 : 659 - 664
  • [7] Recent developments in the psychopharmacology of anxiety disorders
    Lydiard, RB
    BrawmanMintzer, O
    Ballenger, JC
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1996, 64 (04) : 660 - 668
  • [8] Treatment Implications of Sleep-Related Problems in Pediatric Anxiety Disorders: A Narrative Review of the Literature
    Tan, Wan Jie
    Ng, Melissa S. L.
    Poon, Shi Hui
    Lee, Tih Shih
    [J]. CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 2023, 54 (03) : 659 - 664
  • [9] Narrative review: COVID-19 and pediatric anxiety
    Walsh, Kevin
    Furey, William J.
    Malhi, Narpinder
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 144 : 421 - 426
  • [10] Medicinal Cannabis for the Treatment of Anxiety Disorders: a Narrative Review
    Stack S.K.
    Wheate N.J.
    Schubert E.A.
    [J]. Current Treatment Options in Psychiatry, 2022, 9 (3) : 163 - 173